Stay updated on Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a new build of the ClinicalTrials.gov interface for this record.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision label v3.6.5 has been added to the history, and the previous v3.6.4 label has been removed, indicating an update to the study record's version history.SummaryDifference0.1%

- Check39 days agoChange DetectedThe study record history includes a new Revision: v3.6.4, replacing the previous Revision: v3.6.3, signaling an update to the page's revision log.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page history shows a new revision label, updating from v3.6.2 to v3.6.3, reflecting an update to the page's metadata. This is a UI/system update rather than any changes to trial details.SummaryDifference0.1%

- Check68 days agoChange DetectedThe study record history shows a new revision label 'Revision: v3.6.2' added, replacing the older 'Revision: v3.6.0'. This indicates a site update to the page rather than a substantive content change.SummaryDifference0.1%

- Check82 days agoChange DetectedA recruitment status change indicates no longer looking for participants. The record version has been updated to v3.6.0, replacing the prior v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.